TargetRx to Address Critical Sales and Marketing Issues at Key Pharmaceutical Industry Events

Horsham, PA - November 3, 2006 - TargetRx President and CEO Mike Luby will lead discussion at key pharmaceutical events this November, delivering presentations that will address some of industry's biggest concerns, including the Physician Data Patient Restriction Program and the future of sales and marketing.

Luby will reveal alternatives to traditional pharmaceutical sales and marketing strategies at the Transforming Pharmaceutical Brand Leadership Conference and the Prescription Data Restriction Forum. At each conference, executives from leading pharmaceutical companies including Eli Lilly, AstraZeneca and GlaxoSmithKline will discuss how increased institutional marketing restrictions, an aging consumer base and innovations in physician marketing will shape the future of the pharmaceutical industry. Luby will be delivering the following presentations:

IIR's Transforming Pharmaceutical Brand Leadership
November 6-8, 2006, Chicago, Navy Pier
Chairman: Sales Force Productivity track, Monday, November 6
Chairman: Marketing to Prescribers track, Tuesday, November 7
Panelist: The Future of Physician Marketing, Tuesday, November 7, 4:15-4:55 p.m.

Luby will serve as the chair of the Sales Force Productivity track on Monday, November 6 and the Marketing to Prescribers track on Tuesday, November 7. Luby will open both tracks with a discussion of sales and marketing trends. He will also participate in a panel discussion on The Future of Physician Marketing with panelists from Eyetech Pharmaceuticals, Sanofi-Aventis and Purdue Pharma. This panel of leading marketing experts will discuss the challenges of adapting to the changing arena of physician marketing with innovative strategies to predict and strengthen brand performance.

This year's show, entitled Pharmaceutical Brand Leadership: What's Next?, aims to evaluate and address key topics in the pharmaceutical industry as it continues to grow and evolve. This event will help prepare companies for a new consumer base as the baby boomer generation turns 60, develop forward thinking strategies for leveraging Medicare Part D as a marketing tool and rethink the traditional sales force model. For more information about this event, visit: www.iirusa.com.

CBI's Prescription Data Restriction Forum
November 13-14, 2006, Philadelphia, Doubletree Hotel
Opening Keynote Address: Exploring Alternative Strategies to Physician Prescribing Data that Can Improve Sales Promotional Efforts, Effectiveness and Efficiency
Monday, November 13, 8:45-9:20 a.m.

In his keynote address, Luby will explore how mounting concerns over the availability of physician prescribing data are prompting the industry to re-think its approach to measuring performance and effectiveness. With methods aimed at providing sales and marketing teams in the pharmaceutical industry with powerful information to improve the effectiveness and efficiency of their promotional efforts, the industry will be able to adapt, despite heightened physician concerns and institutional barriers.

This event strives to uncover the effects of the Physician Data Restriction Program, strengthening state regulations, and physicians' concern over the commercial use of their prescription behavior. Featuring pharmaceutical executives from Genentech, Inc., MedPointe Pharmaceuticals and Sepracor Inc., as well as New Hampshire State Representative Cindy Rosenwald, this event promises to bring together all sides of the debate over prescription data restriction and pharmaceutical marketing's response. For more information about this event, visit: www.cbinet.com.

About TargetRx

TargetRx provides pharmaceutical and biotech companies with unique insight into the true drivers of product choice and adoption for their brands, helping clients to confidently take the actions that will grow their businesses and help patients. Serving the majority of the top 30 pharmaceutical and biotech companies, TargetRx enables clients to significantly improve the launch of new products and indications, physician segmentation and targeting, creation of professional messaging and materials, and sales and marketing execution and effectiveness. All TargetRx solutions are powered by our AdvantageBuilderSM normative database and validated predictive models, created from capturing in-depth physician attitudes on the "four forces" of prescribing - product, payor, promotion and patient - on new launches, marketing campaigns and physician-rep interactions on over 500 pipeline and inline brands and modeling these attitudes against actual prescribing behavior. For more information, visit www.targetrx.com.

Media Contact:

Joe Ford
Phone: 215-444-8722
jford@targetrx.com